Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Dose Dense MVAC for Muscle Invasive Bladder Cancer

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Fox Chase Cancer Center
ClinicalTrials.gov Identifier:
NCT01031420
First received: December 3, 2009
Last updated: November 3, 2015
Last verified: November 2015